The RIVAL trial shows there is no difference in rates of composite death, myocardial infarction, stroke or major bleeding between radial access and femoral access strategies, but radial access decreased major vascular complications.
If you enjoy this content, please share it with a colleague
- Read more about Review of the RIVAL Trial
- Log in or register to post comments
